Search

everythinglearnresearchcommunity

for

Search:↓

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

circRNA-1926 helps goat stem cells turn into hair follicles by affecting miR-148a/b-3p and CDK19.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

CDP is crucial for lung and hair follicle cell development.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.

JAK inhibitors are effective treatments for alopecia areata.

ASLNC168501 may help restore hair growth in androgenetic alopecia by improving hair follicle stem cell function.

RORA boosts autophagy in hair follicle stem cells, potentially aiding hair growth.

MC-1R in skin cells may influence inflammation and collagen production.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

The IRE gene is important for normal root hair growth in Arabidopsis plants.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Involucrin gene expression is controlled by specific proteins and signaling pathways.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

RORA plays a key role in controlling seasonal hair molting by affecting hair follicle cell activity.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.